Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Common Equity (2016 - 2025)

Proto Labs' Common Equity history spans 15 years, with the latest figure at $673.9 million for Q4 2025.

  • For Q4 2025, Common Equity rose 0.56% year-over-year to $673.9 million; the TTM value through Dec 2025 reached $673.9 million, up 0.56%, while the annual FY2025 figure was $673.9 million, 0.56% up from the prior year.
  • Common Equity for Q4 2025 was $673.9 million at Proto Labs, up from $664.7 million in the prior quarter.
  • Across five years, Common Equity topped out at $832.0 million in Q1 2022 and bottomed at $656.8 million in Q1 2025.
  • The 5-year median for Common Equity is $686.3 million (2024), against an average of $729.4 million.
  • The largest annual shift saw Common Equity soared 38.4% in 2021 before it dropped 17.9% in 2023.
  • A 5-year view of Common Equity shows it stood at $828.5 million in 2021, then decreased by 15.79% to $697.6 million in 2022, then dropped by 0.34% to $695.3 million in 2023, then fell by 3.62% to $670.2 million in 2024, then increased by 0.56% to $673.9 million in 2025.
  • Per Business Quant, the three most recent readings for PRLB's Common Equity are $673.9 million (Q4 2025), $664.7 million (Q3 2025), and $664.7 million (Q2 2025).